HOSNY et al.
11 of 12
|
O
O
H
N
2
H
N
4
NH2
1
benzoyl isothiocyanate
N
H
N
H
N
N
S
O
N-(2-isonicotinoylhydrazine-carbonothioyl)benzamide
isonicotinic hydrazide
H3L
SCHEME 2 Preparation of the ligand
stream.[50] The spectra were corrected for the dark current
noises and background firstly. Spectral Gaussian peaks were
used to obtain the best-fitted data. The intensity, full width
at half maximum (FWHM) and position of each band were
adjusted automatically by the program, on the basis of the
minimization of the deviations between experimental and
simulated spectrum.[51,52]
100 μL dimethyl sulfoxide (DMSO) was added to each well
to dissolve the purple color of the formed formazan. The
readings were taken at 570 nm by a plate reader (EXL 800,
USA). The relative cell viability in percentage was calculated
as (A570 of treated samples/A570 of untreated sample) × 100.
For comparison, Doxorubicin was used as a standard antican-
cer drug.[53,54]
4.4
Synthesis of the ligand (H3L)
ORCID
|
Isonicotinic hydrazide (0.01 mol) was dissolved in 25 mL
ethanol and to which benzoylisothiocyanate (0.01 mol)
was added dropwise. The reaction mixture was refluxed for
1 hour. After cooling to room temperature, white crystals
were precipitated. After filtration the precipitate was washed
with ethanol and dried in air (m.p.: 232°C). The formation
reaction of the ligand is shown in Scheme 2.
Nasser Mohammed Hosny
REFERENCES
[1] M. Malhotra, M. Sanduja, A. Samad, A. Deep, J. Serb. Chem.
Soc. 2012, 77, 9.
[2] E. Pahontu, D. C. Ilies, S. Shova, C. Oprean, V. Paunescu, O.
T. Olaru, F. S. Radulescu, A. Gulea, T. Rosu, D. Draganescu,
Molecules 2017, 22, 650.
4.5
Synthesis of the metal complexes
|
[3] N. Fahmi, R. Singh, J. Indian Chem. Soc. 1996, 73, 257.
[4] J. R. Dimmock, R. N. Puthucode, J. M. Smith, M. Hetherington, J.
W. Quail, U. Pugazhenthi, T. Lechler, J. P. Stables, J. Med. Chem.
1996, 39, 3984.
The equivalent amount of the divalent copper, cobalt, nickel,
and zinc acetates (0.01 mol) were dissolved in 25 mL abso-
lute ethanol, then, added dropwise with stirring to the hot so-
lution of H3L (0.01 mol). Colored precipitates were formed
on addition. The mixtures were filtered off while hot, washed
successfully with ethanol, and dried in air.
[5] J. Dimmock, K. Sidhu, S. Tumber, S. Basran, M. Chen, J. Quail,
J. Yang, I. Rozas, D. Weaver, Eur. J. Med. Chem. 1995, 30,
287.
[6] J. Dimmock, S. Pandeya, J. Quail, U. Pugazhenthi, T. Allen, G.
Kao, J. Balzarini, E. DeClercq, Eur. J. Med. Chem. 1995, 30, 303.
[7] T. S. Lobana, R. Sharma, G. Bawa, S. Khanna, Coord. Chem. Rev.
2009, 253, 977.
4.6
Cytotoxicity assay
|
[8] N. Nawar, E. El-Sawaah, N. M. Hosny, M. M. Mostafa,
Phosphorus Sulfur 2012, 187, 976.
The cell lines HePG-2 and HCT-116 were used to measure
the inhibitory effects of the ligand (H3L) and its Zn(II) com-
plex on cell growth using the colorimetric assay MTT. This
method is based on the conversion of the yellow color of
tetrazolium bromide (MTT) to the purple color of formazan
derivative by mitochondrial succinate dehydrogenase in vi-
able cells. RPMI-1640 medium with 10% fetal bovine serum
was used to culture the cell lines. The added antibiotics were
100 μg/mL Streptomycin and 100 units/mL Penicillin in a
5% CO2 incubator at 37°C. The cell lines were seeded in a
96-well plate at a density of 1.0 × 104 cells/well at 37°C for
48 h under 5% CO2. After incubation, the cells were treated
with different concentration of H3L and its Zn complex and
incubated for 24 hour. After drug treatment, 20 μL of MTT
solution at 5 mg/mL was added and incubated for 4 hour.
[9] K. Uesugi, L. J. Sik, H. Nishioka, T. Kumagai, T. Nagahiro,
Microchem. J. 1994, 50, 88.
[10] N. Farrell, Coord. Chem. Rev. 2002, 232, 1.
[11] D. L. Klayman, J. P. Scovill, J. F. Bartosevich, J. Bruce, J. Med.
Chem. 1983, 26, 35.
[12] R. M. Roat-Malone, Bioinorganic Chemistry: A Short Course,
John Wiley & Sons, Hoboken, NJ 2007.
[13] N. K. Singh, S. B. Singh, Transition Met. Chem. 2001, 26, 487.
[14] R. Rastogi, M. Yadav, K. Singh, Synth. React. Inorg. Met. Org.
Chem. 2003, 33, 1585.
[15] M. I. Orif, M. H. Abdel-Rhman, Polyhedron 2015, 98, 162.
[16] N. M. Hosny, N. Y. Hassan, H. M. Mahmoud, M. H. Abdel-
Rhman, J. Mol. Struct. 2018, 1156, 602.
[17] M. Joseph, M. Kuriakose, M. P. Kurup, E. Suresh, A. Kishore, S.
G. Bhat, Polyhedron 2006, 25, 61.